Literature DB >> 23173832

Persistence of Mycobacterium bovis bacillus Calmette-Guérin (BCG) Danish in white-tailed deer (Odocoileus virginianus) vaccinated with a lipid-formulated oral vaccine.

M V Palmer1, T C Thacker, W R Waters, S Robbe-Austerman, F E Aldwell.   

Abstract

Mycobacterium bovis, the causative agent of tuberculosis in animals, has a broad host range, including humans. Historically, public health concerns prompted programs to eradicate tuberculosis from cattle in many nations. Eradication efforts decreased the prevalence of bovine tuberculosis; nevertheless, some countries encountered significant obstacles, not least of which was a wildlife reservoir of M. bovis. Efforts to decrease the size of the affected wildlife populations have neither eliminated disease nor eliminated transmission to cattle. Consequently, the use of a vaccine for wildlife is being explored. The vaccine most studied is M. bovis BCG, an attenuated live vaccine, first developed 100 years ago. The most efficient and effective means of vaccinating wildlife will be an oral vaccine. White-tailed deer in Michigan, USA, constitute a reservoir of M. bovis. White-tailed deer are a popular game species, and as such, represent a food animal to many hunters. BCG persistence in deer tissues could result in human exposure to BCG. Although non-pathogenic, BCG exposure could induce false-positive skin test results, confounding the central component of public health surveillance for TB. The objective of the present study in white-tailed deer was to evaluate persistence of lipid-encapsulated BCG and a liquid suspension of BCG after oral administration at two different dosages. Vaccine was not recovered at any time after oral consumption of a bait containing a single dose (1 × 10(8) CFU) of lipid-encapsulated BCG. However, persistence was consistent in deer consuming 10 lipid-encapsulated baits (1 × 10(9) CFU), with BCG recovered from at least one deer at 1, 3, 6, 9 and 12 months after consumption. Persistence of up to 9 months was seen in deer vaccinated with orally with a liquid suspension. Persistence of BCG was limited to lymphoid tissue and never found in samples of muscle collected at each time point. Although the risk of exposure to hunters is low, BCG persistence should be considered prior to field use in white-tailed deer. Published 2012. This article is a US Government work and is in the public domain in the USA.

Entities:  

Keywords:  BCG; Mycobacterium bovis; Odocoileus; deer; lipid; oral; persistence; vaccination

Mesh:

Substances:

Year:  2012        PMID: 23173832     DOI: 10.1111/tbed.12032

Source DB:  PubMed          Journal:  Transbound Emerg Dis        ISSN: 1865-1674            Impact factor:   5.005


  5 in total

Review 1.  Application of encapsulated nano materials as feed additive in livestock and poultry: a review.

Authors:  Duraisamy Rajendran; Preedia Babu Ezhuthupurakkal; Rithu Lakshman; Nisarani Kollurappa Shivakumar Gowda; Ayyasamy Manimaran; Somu Bn Rao
Journal:  Vet Res Commun       Date:  2022-02-14       Impact factor: 2.459

2.  Fecal Volatile Organic Ccompound Profiles from White-Tailed Deer (Odocoileus virginianus) as Indicators of Mycobacterium bovis Exposure or Mycobacterium bovis Bacille Calmette-Guerin (BCG) Vaccination.

Authors:  Randal S Stahl; Christine K Ellis; Pauline Nol; W Ray Waters; Mitchell Palmer; Kurt C VerCauteren
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

Review 3.  Challenges for controlling bovine tuberculosis in South Africa.

Authors:  Luke F Arnot; Anita Michel
Journal:  Onderstepoort J Vet Res       Date:  2020-02-27       Impact factor: 1.792

4.  Oral vaccination of white-tailed deer (Odocoileus virginianus) with Mycobacterium bovis Bacillus Calmette-Guerin (BCG).

Authors:  Mitchell V Palmer; Tyler C Thacker; W Ray Waters; Suelee Robbe-Austerman
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

Review 5.  Use of the Human Vaccine, Mycobacterium bovis Bacillus Calmette Guérin in Deer.

Authors:  Mitchell V Palmer; Tyler C Thacker
Journal:  Front Vet Sci       Date:  2018-10-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.